Prevalence of Multidrug-Resistant Tuberculosis in HIV/Tuberculosis Co-Infected Patients
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Tuberculosis (TB) is a common opportunistic infection in human immunodeficiency virus (HIV)-infected patients. Patients with multidrug-resistant (MDR)-TB have poor outcomes. This study aimed to determine the prevalence of MDR-TB in HIV/TB co-infected patients in the Korea. We reviewed the medical records of HIV/TB co-infected patients at two university hospitals between January 1998 and December 2020. During the study period, a total of 87 HIV/TB co-infected patients were identified, and drug susceptibility test results were available for 44 of them. The prevalence of MDR-TB in the study population was 15.9% (7/44, 95% confidence interval, 5.1 - 26.7).
Abstract
Tuberculosis (TB) is a common opportunistic infection in human immunodeficiency virus (HIV)-infected patients. Patients with multidrug-resistant (MDR)-TB have poor outcomes. This study aimed to determine the prevalence of MDR-TB in HIV/TB co-infected patients in the Korea. We reviewed the medical records of HIV/TB co-infected patients at two university hospitals between January 1998 and December 2020. During the study period, a total of 87 HIV/TB co-infected patients were identified, and drug susceptibility test results were available for 44 of them. The prevalence of MDR-TB in the study population was 15.9% (7/44, 95% confidence interval, 5.1 - 26.7).
참고문헌 (11)
- Oh MD, "Spectrum of opportunistic infections and malignancies in patients with human immunodeficiency virus infection in South Korea", Clin Infect Dis, 29, pp.1524~1528 (1999)
- 최윤수, "Epidemiological characteristics of HIV infected Korean: Korea HIV", AIDS Cohort Study, 2019, pp.41, 1~9[DOI]
- 황정환, "Incidence and Risk Factors of Tuberculosis in Patients with Human Immunodeficiency Virus Infection", Journal of Korean Medical Science, 28(3), pp.374~377 (2013), 대한의학회
- Post FA, "Multi-drug-resistant tuberculosis in HIV positive patients in Eastern Europe", J Infect, 68, pp.259~263 (2014)
- 이선희, "Is Multi-Drug Resistant Tuberculosis More Prevalent in HIV-Infected Patients in Korea?", Yonsei Medical Journal, 57(6), pp.1508~1510 (2016), 연세대학교의과대학[DOI]
- 조준성, "Proportion of Multidrug-Resistant Tuberculosis in Human Immunodeficiency Virus", Mycobacterium tuberculosis Co-Infected Patients in Korea, 2012, pp.27(10), 1143~1146[DOI]
- Meeting report of the WHO expert consultation on the definition of extensively drug resistant tuberculosis, "World Health Organization (WHO)", WHO, ~ (2021)
- Lee M, "Multidrugresistant tuberculosis in South Korea : a retrospective analysis of national registry data in 2011-2015", Int J Tuberc Lung Dis, 23, pp.850~857 (2019)
- 김현석, "Trend of multidrug and fluoroquinolone resistance in Mycobacterium tuberculosis isolates from 2010 to 2014 in Korea: a multicenter study", The Korean Journal of Internal Medicine, 34(2), pp.344~352 (2019), 대한내과학회[DOI]
- 전두수, "Treatment Outcome and Mortality among Patients with Multidrug-resistant Tuberculosis in Tuberculosis Hospitals of the Public Sector", Journal of Korean Medical Science, 26(1), pp.33~41 (2011), 대한의학회
- Bhering M, "Treatment outcomes and predictive factors for multidrug-resistant TB and HIV coinfection in Rio de Janeiro State, Brazil", Int J Tuberc Lung Dis, 25, pp.292~298 (2021)